Biosimilar, Gene Therapy Approval Top SPT Week in Review

Top articles of the week from Specialty Pharmacy Times.

5. Class-action Lawsuit: Aetna Faces Punishment for HIV Privacy Breach

Approximately 12,000 customers were affected by the breach.

Click to read more…

4. Pharmacists in Texas Provide Calm Amidst the Storm of Hurricane Harvey

Texas-based pharmacies work to ensure access to lifesaving medications for patients displaced and homeless due to the flooding caused by Hurricane Harvey.

Click to read more…

3. FDA Greenlights Fulvestrant Monotherapy for Expanded Use in Advanced Breast Cancer

Faslodex reduced disease progression by 20% among women with HR+, HER2- advanced breast cancer.

Click to read more…

2. Second Humira Biosimilar Approved in the United States

Cyltezo approved for the same indications as Humira, including rheumatoid arthritis, psoriatic arthritis, and Crohn’s disease.

Click to read more…

1. FDA Approves First Gene Therapy in the United States

Tisagenlecleucel is indicated for pediatric and young adult patients with B-cell precursor acute lymphoblastic leukemia.

Click to read more…